Physician
Bourjas, Lina
Bourjas, Lina was paid $288K by Medicaid between Jun 2022 and Aug 2024, across 28 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 28% of everything it billed.
33Billing provider infoBOURJAS, LINA
NAPERVILLE, IL 60563
NAPERVILLE, IL 60563
33aNPI1023503448assigned 06/27/2018
33bProvider typePediatrics Physician
28Total paid$288K
24GClaims5,660
24DCodes billed28
24AFirst – last monthJun 2022 – Aug 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#433 of 1,805
Median peer was paid$55K
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 2,840 | $148K | |
| 2023 | 2,805 | $140K | |
| 2024incomplete | 15 | $135.30 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 28% | 559 | 408 | $79K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 1,101 | 800 | $79K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 978 | 717 | $44K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.1% | 232 | 155 | $15K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.9% | 595 | 441 | $14K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.6% | 199 | 130 | $13K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.1% | 170 | 107 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.6% | 104 | 70 | $7K |
| 92551 | 1.7% | 328 | 221 | $5K | |
| 96127 | 1.3% | 194 | 135 | $4K | |
| 90686 | <1% | 127 | 72 | $2K | |
| 90698 | <1% | 118 | 64 | $2K |
16 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 104 | $2K |
| 99173 | <1% | 164 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 73 | $1K |
| 90671 | <1% | 53 | $1K | |
| 90680 | <1% | 64 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 24 | $993.12 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 17 | $872.27 |
| 90670 | <1% | 48 | $797.93 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 25 | $782.50 |
| 85018 | <1% | 244 | $566.94 | |
| 83655 | <1% | 34 | $403.24 | |
| 90744 | <1% | 17 | $279.92 | |
| 83718 | <1% | 30 | $233.44 | |
| 90619 | <1% | 13 | $217.23 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $135.30 |
| 82465 | <1% | 30 | $127.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.